Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > More shares for insiders

<< Previous

Bullboard Posts

Next >>

Post by money4golfon Nov 23, 2022 8:57am

293 Views

Post# 35121200

More shares for insiders

Filing
Date Transaction
Date Insider Name Ownership
Type Securities Nature of transaction Volume or Value Price Nov 22/22 Nov 21/22 Stevens, William Charles Direct Ownership Deferred Share Units 56 - Grant of rights 35,833 Nov 22/22 Nov 21/22 Bihl, Anthony Phillip Direct Ownership Deferred Share Units 5

Nov 22/22 Nov 21/22 Stevens, William Charles Direct Ownership Deferred Share Units 56 - Grant of rights 35,833
Nov 22/22 Nov 21/22 Bihl, Anthony Phillip Direct Ownership Deferred Share Units 56 - Grant of rights 63,207

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features